Crohn’s disease is a chronic inflammatory bowel disease that is sometimes insufficiently controlled by immunosuppressive therapies with a subsequent need for surgical removal of affected bowel segments.
Clearmind Medicine Granted Patent Approval in Hong Kong for its Binge Behaviors Treatment | Psychedelic Invest
Vancouver, Canada, June 28, 2024 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the “Company”), a clinical-stage biotech company focused on